U.S. Markets closed

MDT’s Diabetes Business Could Significantly Boost Its Revenue

Daniel Collins
MDT’s Diabetes Business Could Significantly Boost Its Revenue

In fiscal Q4 2018, Medtronic’s (MDT) Diabetes segment generated revenue of $645 million compared to $512 million in fiscal 2017, which reflected a ~26% rise YoY (year-over-year).